{"certainAgreement":{"piSponsorEmployee":true},"limitationsAndCaveats":{"description":"No pharmaco-dynamic marker to support an effect of signaling downregulation in lenalidomide-refractory patients to corroborate low dose thalidomide (50-100 mg) with or without dexamethasone has a therapeutic benefit with lenalidomide."},"pointOfContact":{"email":"dmweber@mdanderson.org","organization":"UT MD Anderson Cancer Center","phone":"713-792-2860","title":"Weber,Donna M.,M.D. / Lymphoma/Myeloma"}}